x

We are the company we keep. At Market Ready Rx, we believe our partners provide our clients more experience and more depth in our quality services. We bring our partners to an engagement either as an extension of the Market Ready Rx team or as another resource for you to engage directly. Our goal is to provide you exceptional services.

 

Atheln is an innovative biopharma consulting and interim management group specializing in the creation of product development and commercial strategies. Atheln"s approach is unique in its integration of commercial and technical disciplines to maximize product value, relentless focus on identifying the key disciplines that the client needs, exclusively utilizing industry seasoned experts, and being solely driven by client success. The Atheln team is a blend of product development and commercial experts with 20 - 45 years of global strategic and operational experience in both Fortune 500 and start-up companies. Market Ready Rx partners with Atheln when expertise in Biopharma development, quality management and commercialization is required by our clients. In turn, Market Ready Rx provides Atheln"s clients companion diagnostic commercialization consulting services.

 

Personalized Medicine Partners, LLC ("PMP"), established in 2004 by Michael Stocum, and is dedicated to increasing the value of therapeutic and diagnostic products, technologies & services through integrated product and business development. PMP creates this value through assessment, research and strategic planning followed by implementation activities that accelerate clinical development, differentiate the products from their competitors, generate market expansion and deliver sales growth. PMP's work in the biomarker, companion therapeutic/diagnostic and personalized medicine space has impacted numerous products across multiple disease areas. Market Ready Rx partners with PMP when clients need help forming a companion diagnostic development strategy that is fully integrated with the therapeutic development plan. In turn, Market Ready Rx provides PMP clients companion diagnostic commercialization consulting services.

 

The RDS Consulting Group was founded by Ramon Seva, a highly experienced professional with 20 years of biotechnology and pharmaceutical industry commercialization experience. Over the past 10 years, Mr. Seva has worked in a consulting capacity with biopharma clients on commercial strategy development for new products, strategic planning, forecasting, and due diligence for licensing. RDS Consulting develops rigorous and sophisticated revenue and valuation models in MS Excel incorporating primary and secondary research. The models are user friendly with documented assumptions and sources. Furthermore, RDS consulting develops and fields quantitative studies that provides inputs to revenue and valuation models. The quantitative studies typically target healthcare providers and patients to better quantify perceptions on product preference and changes in product preference due to various changes in product attributes or competitive product attributes. Market Ready Rx partners with RDS Consulting when quantitative market research studies and valuation expertise is required by our clients. In turn, Market Ready Rx provides RDS clients IVD and companion diagnostic strategic commercialization consulting services.

 

Scholz Consulting Partners is a group of experienced business and technology experts led by Manfred Scholz PhD, serving the clinical diagnostic industry by developing strategies for in vitro diagnostics and closely related markets. SCP Consulting’s unique blend of hands-on technical, operational and commercial experience, education (MBAs and PhDs), combined with extensive market intelligence enables efficient strategy development, investment due diligence as well as merger & acquisition support. The business is based in the Boston area and has an affiliate office in Tokyo. The team consults globally and has its strongest project experience in China, Japan, Europe and North America. Market Ready Rx partners with Scholz Consulting Partners when expertise is required for IVD strategy development and early stage company investment strategies. In turn, Market Ready Rx provides Scholz Consulting Partners' clients with companion diagnostic strategy expertise and commercialization consulting services.